Inactive Instrument

News Coronado Biosciences Inc Nasdaq

Equities

US21976U1097

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024	Apr. 25	AQ
Avenue Therapeutics Announces Reverse Stock Split	Apr. 24	AQ
North American Morning Briefing : Powell Awaited -2-	Apr. 03	DJ
Certain Warrants of Fortress Biotech, Inc. are subject to a Lock-Up Agreement Ending on 2-APR-2024.	Apr. 01	CI
Certain Options of Fortress Biotech, Inc. are subject to a Lock-Up Agreement Ending on 2-APR-2024.	Apr. 01	CI
Certain Common Stock of Fortress Biotech, Inc. are subject to a Lock-Up Agreement Ending on 2-APR-2024.	Apr. 01	CI
Fortress Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights	Mar. 28	AQ
Avenue Therapeutics to Host Virtual Key Opinion Leader Event on April 4, 2024	Mar. 26	AQ
Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights	Mar. 21	AQ
Alliance Global Partners Initiates Fortress Biotech at Buy Rating With $5 Price Target	Mar. 19	MT
Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea	Mar. 18	AQ
Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024	Mar. 15	AQ
Journey Medical Corporation to Participate in the 36th Annual ROTH Conference	Mar. 13	AQ
Fortress Biotech to Participate in 36th Annual ROTH Conference	Mar. 12	AQ
Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting	Mar. 11	AQ
Fortress Biotech and Cyprium Therapeutics Announce $4.1 Million Grant from NINDS to Further Development of AAV-ATP7A Gene Therapy for Menkes Disease	Mar. 04	AQ
Certain Preferred Stock of Fortress Biotech, Inc. are subject to a Lock-Up Agreement Ending on 8-FEB-2024.	Feb. 07	CI
Certain Common Stock of Fortress Biotech, Inc. are subject to a Lock-Up Agreement Ending on 8-FEB-2024.	Feb. 07	CI
Lindsay RosenwaldÃ¢€™s Fortress Bio (NASDAQ: FBIO) Spotlight on 2024 Milestones from Subsidiaries	Feb. 02	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Coronado Biosciences Inc Nasdaq

Equities

US21976U1097

Summary

Filters